Cerebrovascular accident (CVA) is a major complication of sickle cell
disease, The incidence and mortality of and risk factors for CVA in si
ckle cell disease patients in the United States have been reported onl
y in small patient samples. The Cooperative Study of Sickle Cell Disea
se collected clinical data on 4,082 sickle cell disease patients enrol
led from 1978 to 1988. Patients were followed for an average of 5.2 +/
- 2.0 years, Age-specific prevalence and incidence rates of CVA in pat
ients with the common genotypes of sickle cell disease were determined
, and the effects of hematologic and clinical events on the risk of CV
A were analyzed, The highest rates of prevalence of CVA (4.01%) and in
cidence (0.61 per 100 patient-years) were in sickle cell anemia (SS) p
atients, but CVA occurred in all common genotypes, The incidence of in
farctive CVA was lowest in SS patients 20 to 29 years of age and highe
r in children and older patients, Conversely, the incidence of hemorrh
agic stroke in SS patients was highest among patients aged 20 to 29 ye
ars, Across all ages the mortality rate was 26% in the 2 weeks after h
emorrhagic stroke. No deaths occurred after infarctive stroke, Risk fa
ctors for infarctive stroke included prior transient ischemic attack,
low steady-state hemoglobin concentration and rate of and recent episo
de of acute chest syndrome, and elevated systolic blood pressure, Hemo
rrhagic stroke was associated with low steady-state hemoglobin and hig
h leukocyte count, (C) 1998 by The American Society of Hematology.